# Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

> **NCT00976820** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 323 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK2340274A
- **BIOLOGICAL:** GSK2340273A

## Key facts

- **NCT ID:** NCT00976820
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-20
- **Primary completion:** 2011-03-21
- **Final completion:** 2011-03-21
- **Target enrollment:** 323 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976820, "Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00976820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*